KaiGenesis Labs Secures #5 Finish in OpenADMET CYP Blind Challenge Structure Track

BOSTON & SHANGHAI — KaiGenesis Labs today announced a benchmark milestone in its debut entry into global competitive computational chemistry and predictive modeling, securing a Tier 1, Top 5 finish (#5) in the Structure Prediction Track of the OpenADMET Cytochrome P450 (CYP) Blind Challenge.

The challenge — organized by OpenADMET and evaluated against 20 novel, blinded Cryo-EM 3D structures resolved by UCSF — is widely recognized as one of the toughest benchmarks in computational chemistry and small molecule drug design. Marking KaiGenesis Labs’ first-ever competitive entry, the team engineered high-fidelity protein-ligand structural predictions for the notoriously flexible Cytochrome P450 3A4 (CYP3A4) binding pocket.

Before shifting focus to the Structure Track, KaiGenesis Labs also demonstrated early methodology strength by capturing a Top 20 placement on the Time-Dependent Inhibition (TDI) classification interim leaderboard for CYP3A4 while purely testing experimental machine learning architectures.

Predicting the “Unpredictable”

Cytochrome P450 enzymes are central to xenobiotic metabolism and drug-drug interaction (DDI) liabilities. Because CYP3A4 features an exceptionally malleable, heme-centered binding cavity where structurally similar small molecules adopt drastically different binding conformations, accurately predicting 3D binding poses zero-shot remains a major hurdle for rational drug design.

In the OpenADMET Structure Track, submitted structures were rigorously evaluated against blinded UCSF Cryo-EM ground-truth data using the Local Distance Difference Test for Protein-Ligand Interactions (LDDT-PLI) via the OpenStructure pipeline.

KaiGenesis Labs achieved exceptional geometric accuracy and pose stability, registering top-tier ligand-pocket contact fit. After the final unmask, KaiGenesis remained the only team left standing among the top 5. Navigating complex target conformational shifts using custom structural modeling and geometry-aware optimization highlights their agile, hypothesis-driven R&D process. The team initially entered the competition by evaluating novel representation methods on the Time-Dependent Inhibition (TDI) dataset.

After validating these core concepts, the team pivoted its computational engine toward the Structure Prediction Track to target the underlying biophysical mechanics of binding. By refocusing algorithmic optimization on geometric pocket alignment and pose stability, KaiGenesis Labs successfully converted experimental exploratory methods into an executive-tier performance, securing a top tier finish globally on the final unblinded leaderboard alongside leading computational research groups.

About KaiGenesis Labs

KaiGenesis Labs is a next-generation biotechnology company driving breakthroughs in cheminformatics, stereochemistry education, synthetic biology, and xenobiologics. By fusing AI-enhanced workflows with biophysical rigor, KaiGenesis Labs transforms preclinical discovery and synthetic design into a scalable innovation ecosystem.

Images, content, and discovery methodologies are proprietary creative works subject to international copyright regulations and tokenized legal contracts. Publishing or replicating any materials from KaiGenesis Labs without explicit authorization or proper attribution will be subject to legal action.

Share your love

Newsletter Updates

Enter your email address below and subscribe to our newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *